Chinook Therapeutics, Inc.

RHUMBLINE ADVISERS

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/8/2023

Shares

89,242

Value ($000)

3,429

Weight

0.0%

2020 Q4 - 2023 Q2 (11 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/8/2023	3,429	0.0%	89,242	6/30/2023
2023 Q1	5/11/2023	1,893	0.0%	81,771	3/31/2023
2022 Q4	2/14/2023	2,125	0.0%	81,093	12/31/2022
2022 Q3	11/10/2022	1,508	0.0%	76,711	9/30/2022
2022 Q2	8/11/2022	1,109	0.0%	63,397	6/30/2022
2022 Q1	5/12/2022	821	0.0%	50,184	3/31/2022
2021 Q4	2/10/2022	747	0.0%	45,822	12/31/2021
2021 Q3	11/12/2021	524	0.0%	41,083	9/30/2021
2021 Q2	8/5/2021	556	0.0%	39,388	6/30/2021
2021 Q1	5/6/2021	249	0.0%	16,048	3/31/2021
2020 Q4	2/10/2021	267	0.0%	16,818	12/31/2020